|
|
|
Volumn 33, Issue 1, 2006, Pages 39-42
|
|
Pilot study of primary systemic chemotherapy with docetaxel (DOC), epirubicin (EPI) and capecitabine (Xeloda) in patients with advanced breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAPECITABINE;
DEOXYCYTIDINE;
DOCETAXEL;
DRUG DERIVATIVE;
EPIRUBICIN;
TAXOID;
ADJUVANT CHEMOTHERAPY;
ADULT;
AGED;
ALOPECIA;
ARTICLE;
BREAST TUMOR;
CHEMICALLY INDUCED DISORDER;
DRUG ADMINISTRATION;
FEMALE;
HUMAN;
LEUKOPENIA;
LYMPH NODE;
LYMPH NODE METASTASIS;
MASTECTOMY;
METHODOLOGY;
MIDDLE AGED;
NEUTROPENIA;
PATHOLOGY;
PILOT STUDY;
ADULT;
AGED;
ALOPECIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
EPIRUBICIN;
FEMALE;
HUMANS;
LEUKOPENIA;
LYMPH NODES;
LYMPHATIC METASTASIS;
MASTECTOMY;
MIDDLE AGED;
NEUTROPENIA;
PILOT PROJECTS;
TAXOIDS;
|
|
EID: 33644822356
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
